Eli Lilly CEO Dave Ricks Talks Weight Loss Drugs Success
Bloomberg Talks
Intro
This chapter explores the anti-obesity drug Zepbound, highlighting its active ingredient terzepatide and the complexities of naming pharmaceuticals. The discussion extends to the wider implications of anti-obesity medications on health and societal perceptions.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
